Cerebral arterial spasm. 2. In vitro contractile activity of serotonin in human serum and CSF on the canine basilar artery, and its blockage by methylsergide and phenoxybenzamine.
D000818:Animals; D001488:Basilar Artery / Q000187:drug effects*; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D002546:Ischemic Attack, Transient / Q000134:cerebrospinal fluid* / Q000209:etiology; D008297:Male; D008784:Methysergide / Q000494:pharmacology*; D009119:Muscle Contraction / Q000187:drug effects; D010643:Phenoxybenzamine / Q000494:pharmacology*; D011453:Prostaglandins / Q000494:pharmacology; D012701:Serotonin / Q000008:administration & dosage / Q000097:blood / Q000134:cerebrospinal fluid / Q000494:pharmacology*; D012702:Serotonin Antagonists; D013345:Subarachnoid Hemorrhage / Q000134:cerebrospinal fluid / Q000150:complications; D014662:Vasoconstrictor Agents / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology
D011453:Prostaglandins; D012702:Serotonin Antagonists; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D010643:Phenoxybenzamine; D012701:Serotonin; D008784:Methysergide; D004837:Epinephrine